POSTER SESSION VI Wednesday, March 02, 2005   —  1:00 - 4:00 PM Convention Center, Exhibit Hall B ENDOCRINE PATHOLOGY 54 Hormonal Status Correlates with EGF-R or Ki-67 Expression in Women with Differentiated Papillary Thyroid Carcinoma (D-PTC) (401) FA Candanedo-Gonzalez, M Saqui-Salces, B Rocha, A Gamboa-Dominguez - National Institute of Medical Sciences and Nutrition, Mexico City, Tlalpan, Mexico 55 Bcl-2 Downregulation at RNA and Protein Level in Papillary Thyroid Carcinoma Is Associated with Methylation of Bcl-2 DNA Promoter Region (423) M Nassiri, C Solorzano, G Irvin, M Nadji - University of Miami/Jakson Memorial Hospital, Miami, FL 56 Significance of GLUT-1 Expression in Thyroid Gland Tumors: Its Availability for Discrimination between Papillary Carcinoma and Follicular Carcinoma (429) M Yasuda, H Kajiwara, N Ogane, Y-I Kameda, K-I Tsukinoki, YR Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan; Kanagawa Cancer Center, Yokohama, Kanagawa, Japan; Kanagawa Dental College, Yokosuka, Kanagawa, Japan 57 Papillary Thyroid Carcinomas Display Lower Amounts of Histone H3 Lysine 4 Methylation Compared to Follicular-Type Neoplasms (410) S George, K Dresser, A Khan, A Fischer - Umass Memorial Medical Center, Worcester, MA 58 CEAMCAM1 Is Expressed by Human Thyroid Carcinoma Cells and Represents a Target for Vitamin D3 Therapy (428) W Wei, W Liu, D Winer, AM Bamberger, S Ezzat, SL Asa - University Health Network, University of Toronto, Toronto, ON, Canada; University Hospital, University of Hamburg, Hamburg, Germany; Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada 59 Stromal Cell-Derived Factor-1 Expression in Malignant Thyroid Neoplasms of Follicular Cell Origin and in Atypical Foci in Hashimoto's Thyroiditis (430) SF Zaidi, J Liu, DS Zander - University of Texas Health Science Center at Houston Medical School, Houston, TX 60 Immunohistochemical Expression of Bcl-2, Bcl-x and Bax in Follicular Carcinomas of the Thyroid (412) DM Haynik, RA Prayson - Cleveland Clinic Foundation, Cleveland, OH 61 A CREB3L2-PPARG Fusion Oncoprotein with Unique Activities in Thyroid Cancer (419) W Lui, S Deshpande, P Michalewicz, I Leibiger, B Leibiger, S Thoppe, U Enberg, J Liden, A Hoog, L Farnebo, J Fletcher, C Larsson, T Kroll - Karolinska Hospital, Stockholm, Sweden; Emory University, Atlanta, GA; University of Chicago, Chicago, IL; Brigham and Women's Hospital, Boston, MA 62 p63 Expression in Carcinoma Showing Thymus-Like Differentiation of the Thyroid (CASTLE): Evidence of Thymic Differentiation and Solid Cell Nest Origin (425) JD Reimann, DM Dorfman, V Nosé - Brigham and Women's Hospital; Harvard Medical School, Boston, MA 63 RASSF1A Methylation and BRAF Mutation in Thyroid Tumors (422) N Nakamura, JA Carney, L Jin, LA Erickson, H Zhang, RV Lloyd - Mayo Clinic, Rochester, MN 64 Growth Factor Receptor Expression in Anaplastic Thyroid Carcinoma, Implications for a Therapeutic Approach (407) DD Elliott, AK El-Naggar - UT, MD Anderson Cancer Center, Houston, TX 65 Utility of Thyroglobulin Measurement in Fine-Needle Aspiration Biopsy Specimens of Lymph Nodes in the Diagnosis of Recurrent Thyroid Carcinoma (399) ZW Baloch, J Walsh, VA LiVolsi, JE Langer, SJ Mandel - UPENN Med Ctr, Philadelphia, PA 66 Fractional Allelic Loss Can Assist in Differentiating Benign from Malignant Parathyroid Neoplasia (414) JL Hunt, J Murphy, EL Barnes - University of Pittsburgh, Pittsburgh, PA 67 Study on the Expression of Pituitary Tumor-Transforming Gene (PTTG) in Human Pituitary Adenomas by Real Time RT-PCR and Immunohisitochemistry (420) T Minematsu, M Yamazaki, S Takekoshi, S Miyai, N Sanno, A Teramoto, RY Osamura - Tokai University School of Medicine, Kanagawa, Japan; Nippon Medical School, Tokyo, Japan 68 Immunohistochemical Study of Tumor Angiogenic Factors in Human Pituitary Adenomas (424) M Niveiro, FI Aranda, G Peiró, C Alenda, A Payá, FM Peiró, A Picó - Hospital General Universitario, Alicante, Spain 69 Immunohistochemical Expression of Neuroendocrine Secretory Protein-55 (NESP-55) in Pituitary Adenomas (411) M Gupta, A Srivastava, RV Lloyd, R Fischer-Colbrie, AS Tischler, Y Dayal - Tufts-New England Medical Center, Boston, MA; Mayo Clinic, Rochester, MN; University of Innsbruck, Innsbruck, Austria 70 Double Adenomas of the Pituitary: Transcription Factors Pit-1, T-pit, and SF-1 Identify Cytogenesis and Differentiation (417) RA Jastania, KO Alsaad, K Kovacs, SL Asa - University Health Network, University of Toronto, Toronto, ON, Canada; St. Michael's Hospital, University of Toronto, Toronto, ON, Canada 71 The Pituitary in Klinefelter Syndrome (427) BW Scheithauer, M Moschopulos, Ö Kurtkaya-Yapicier, K Kovacs, BS Jhaveri, T Percek, RV Lloyd - Mayo Clinic, Rochester, MN; Marmara University, Istanbul, Turkey; St. Michael's Hospital, University of Toronto, Toronto, ON, Canada; St. John's Hospital, Springfield, IL 72 Bilateral Adrenal Myelolipomas: Association with Adrenal Cortical Hyperplasia and Congenital Syndromes (418) D Koutsogiannis, RH Young, CA Meier, M Bongiovanni, JC Pache, WC Faquin - University of Western Ontario, London, ON, Canada; Massachusetts General Hospital, Boston, MA; University Hospital Geneva, Geneva, Switzerland 73 Cytokeratin Expression in Adrenocortical Carcinoma (405) Y Ding, BI Aswad, SJ Shin, RA DeLellis - Rhode Island and The Miriam Hospitals and Brown Medical School, Providence, RI; Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY 74 Expression of NOTCH3 Protein Identifies a Distinctive Subset of Pheochromocytomas (404) PL Dahia, JF Powers, SA Ehsani, AS Tischler - Dana-Farber Cancer Institute, Boston, MA; Tufts New England Medical Center, Boston, MA 75 Clinicopathologic and Anti-Utrophin Immunohistochemical Correlation in Sporadic Pancreatic Endocrine Tumors (402) MC Chang, S Xiao, V Nosé - Brigham and Women's Hospital, Harvard Medical School, Boston, MA 76 Expression of Transcription Factors CDX-2 and TTF-1 in Extrapulmonary Neuroendocrine Carcinomas (406) YM EL-Gohary, P Cho, RS Saad, YL Liu, JF Silverman - Allegheny General Hospital, Pittsburgh, PA